Advertisement
Research Article

Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)

  • Alexander Strom equal contributor mail,

    equal contributor Contributed equally to this work with: Alexander Strom, Hubert Kolb

    alexander.strom@ddz.uni-duesseldorf.de

    Affiliation: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

    X
  • Hubert Kolb equal contributor,

    equal contributor Contributed equally to this work with: Alexander Strom, Hubert Kolb

    Affiliation: Immunobiology Research Group, University Hospital, University of Düsseldorf, Düsseldorf, Germany

    X
  • Stephan Martin,

    Affiliation: West-German Centre of Diabetes and Health, Verbund Katholischer Kliniken Düsseldorf, Düsseldorf, Germany

    X
  • Christian Herder,

    Affiliation: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

    X
  • Marie-Christine Simon,

    Affiliation: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

    X
  • Wolfgang Koenig,

    Affiliation: Department of Internal Medicine II - Cardiology, University of Ulm Medical Center, Ulm, Germany

    X
  • Tim Heise,

    Affiliation: Profil Institute for Metabolic Research, Neuss, Germany

    X
  • Lutz Heinemann,

    Affiliation: Profil Institute for Metabolic Research, Neuss, Germany

    X
  • Michael Roden,

    Affiliations: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany, Department of Metabolic Diseases, University Hospital, Düsseldorf, Germany

    X
  • Nanette C. Schloot,

    Affiliations: Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany, Department of Metabolic Diseases, University Hospital, Düsseldorf, Germany

    Current address: BU Diabetes, Lilly Deutschland GmbH, Bad Homburg, Germany

    X
  • on behalf of the DIATOR Study Group

    A complete list of the DIATOR Study Group can be found in the Acknowledgments.

    X
  • Published: March 20, 2012
  • DOI: 10.1371/journal.pone.0033108

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.